Gabapentin and motor fluctuations in Parkinson's disease

Movement Disorders

Volumn 12, Issue 4, 1997, Pages 608-

  Chana, P ^a   De Marinis, A ^a   Barrientos, N ^a  

^a HOSPITAL DIPRECA   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SOMNOLENCE;

EID: 0030819940     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120421     Document Type: Article

References (4)

1. 1 Olson WL, Gruenthal M, Mueller ME, Olson WH. Gabapentin for parkinsonism: a double‐blind, placebo‐controlled crossover trial. Mov Disord 1996 ; 11: 597–598.
2. 2 Langton JW, Windner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). In: Lindvall O, Bjorklund A, Widner H, eds. Intracerebral transplantation in movement disorders. Amsterdam, The Netherlands: Elsevier, 1991: 227–241.
3. 3 Goa KL, Sorkin EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs 1993 ; 46: 409–427.
4. 4 Suman‐Chauhan N, Webdale L, Hill DR, Woodruff GN. Characterisation of [ 3 H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 1993 ; 244: 293–330.